CIDP


Also found in: Dictionary, Medical, Acronyms.
Related to CIDP: CIPD

CIDP

Crop Insurance and Disaster Payments. Any payments one receives from an insurance policy covering agricultural real estate. One lists CIDP on Form 4835 or Schedule F.
References in periodicals archive ?
Male gender was predominant in acute-onset CIDP group (68.5%, n=37).
We hereby report an interesting case of CIDP in association with Type 1 Diabetes in a 16-year-old female patient with unilateral ptosis, non-healing vascular ulcer in left foot and associated coloboma iris and coloboma choroid.
Two subjects (one'TM Only"and one "FM+RA") who originally met criteria for "Possible CIDP" were reclassified as non-CIDP subjects due to the potential influence of a change in our low filter settings (see Electrodiagnostic Studies above) on determining prolongation of the distal CMAP duration (14, 15, 17).
In contrast, in CIDP the nerve damage occurs because the body's immune system erroneously attacks the myelin sheath, a fatty structure that covers and protects nerves as well as the axons.
AIDP, CIDP, and hypoKPP were all considered in the differential diagnosis.
Nerve root hypertrophy is also present in CIDP. It is difficult to distinguish CMT 1A from CIDP basing on findings on MRI alone.
MEDEROS, P., 1987: Condiciones paleogeograficas de formacion de fosforitas en la region Guines-Pipian.- Ser Geol CIDP (2): 68-83.
* In chronic inflammatory demyelinating polyneuropathy (CIDP), patients develop stepwise nerve dysfunction over many weeks to months.
It's all the more extraordinary as Bradley has a range of conditions that make interacting with others difficult: autism, ADHD (Attention Deficit Hyperactivity Disorder) and CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), a rare neurological disorder which means he can't feel physical pain.
[USPRwire, Mon May 04 2015] Global Markets Direct's, 'Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015', provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)'s therapeutic pipeline.
Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), immunodeficiency are the most prominent disease classes, collectively contributing about 53% of the global IVIG market revenue in 2014.